ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+90.6%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$582M
AUM Growth
+$582M
Cap. Flow
+$25.1M
Cap. Flow %
4.32%
Top 10 Hldgs %
97.63%
Holding
16
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

1
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
$29.3M

Top Sells

1
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$4.16M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$284M 48.72%
3,989,412
– –
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$148M 25.39%
1,123,630
– –
HRMY icon
3
Harmony Biosciences
HRMY
$2.12B
$30.5M 5.23%
842,815
– –
SPRB
4
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$29.3M 5.03%
+1,205,511
New +$29.3M
SNDX icon
5
Syndax Pharmaceuticals
SNDX
$1.41B
$22.8M 3.91%
1,025,000
– –
TECX
6
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$14.1M 2.42%
1,009,779
– –
SYRE icon
7
Spyre Therapeutics
SYRE
$996M
$13.3M 2.29%
1,691,151
– –
PSTX
8
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$11.4M 1.97%
1,043,267
– –
VRNA
9
Verona Pharma
VRNA
$9.16B
$9.33M 1.6%
1,332,485
– –
BCEL
10
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$6.26M 1.08%
387,653
– –
ACRS icon
11
Aclaris Therapeutics
ACRS
$209M
$4.11M 0.7%
634,455
– –
MRKR icon
12
Marker Therapeutics
MRKR
$12M
$2.9M 0.5%
2,000,000
– –
OBSV
13
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.88M 0.5%
1,386,338
– –
VIRX
14
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.01M 0.35%
1,010,000
– –
ZSAN
15
DELISTED
Zosano Pharma Corporation
ZSAN
$1.43M 0.25%
2,718,226
– –
NBRV
16
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$462K 0.08%
191,028
-1,719,259
-90% -$4.16M